Tower Research Capital (TRC)’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Tower Research Capital (TRC)’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,300	Closed	-$22K	–	5518
2014 Q4	$22K	Buy	+1,300	New	+$18.3K	﹤0.01%	1547
2014 Q2	–	Sell	-3,287	Closed	-$12K	–	5240
2014 Q1	$12K	Buy	+3,287	New	+$12.5K	﹤0.01%	2478
2013 Q4	–	Sell	-8,414	Closed	-$36K	–	5333
2013 Q3	$36K	Buy	8,414 +8,394	+41,970%	+$39.8K	﹤0.01%	2213
2013 Q2	$0	Buy	+20	New	+$69	﹤0.01%	4048

Tower Research Capital (TRC)'s AVNR Position: Q1 2015 in Review

Tower Research Capital (TRC) sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,300 shares — an estimated $22K sold.

Tower Research Capital (TRC) first reported a position in AVNR in Q2 2013 and held it in 4 quarters. The position peaked at $36K in Q3 2013. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Tower Research Capital (TRC) reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Tower Research Capital (TRC) sold 1,300 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $22K.
Tower Research Capital (TRC) first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 4 quarters.
Tower Research Capital (TRC)'s AVANIR PHARMACEUTICALS, INC CL A position peaked at $36K in Q3 2013.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2015, filed 12 May 2015.